Most people assume diabetes is easy to diagnose. You take a blood test, get a number, and that’s it. But in real life, it’s ...

Danish drugmaker Novo Nordisk has announced headline results from REIMAGINE 2, a Phase III study from the global REIMAGINE clinical trial program.

Once-weekly CagriSema significantly reduced HbA1c and body weight vs semaglutide in patients with type 2 diabetes in the REIMAGINE 2 trial.

An HbA1c of 5.7 indicates years of insulin resistance and metabolic damage, says Dr Gagandeep, suggesting pre-diabetes is an early-stage disease.

For adults with T2D, surgery is superior to medical therapy for reducing hemoglobin A1c (HbA1c) levels and achieving weight loss.

HbA1c tests provide an average indication of blood sugar control over the past 2-3 months, which helps in managing diabetes and identifying prediabetes. It is influenced by factors beyond diet, like ...

Novo Nordisk NVO announced positive top-line data from a late-stage study in its global REIMAGINE clinical study program for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Use of the Omnipod 5 led to an HbA1c reduction of 0.8 ...

CagriSema achieved superior weight loss of up to 14.2%, where up to 43% of the people achieved ≥15% weight loss and up to 24% ...

Women typically develop diabetes mellitus at a later age than men; however, women often have a higher mortality rate than men due to this condition. This has caused researchers to question whether the ...

The combination of cagrilintide 2.4 mg and semaglutide 2.4 mg was superior to semaglutide alone for weight loss and HbA1c ...